 Home > Encyclopedia > Lapatinib ditosylate monohydrate

Lapatinib ditosylate monohydrate

Lapatinib ditosylate monohydrate structure

CAS No:
388082-78-8
Formula:
C29H26ClFN4O4S.2C7H8O3S.H2O
Chemical Name:
Lapatinib ditosylate monohydrate
Synonyms:
4-Quinazolinamine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-,4-methylbenzenesulfonate,hydrate (1:2:1);4-Quinazolinamine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-,bis(4-methylbenzenesulfonate),monohydrate;Lapatinib ditosylate monohydrate
Categories:
Specialty Chemicals

Description

Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].

Lapatinib ditosylate monohydrate Basic Attributes

Molecular Weight：

943.476

Exact Mass：

942.184143

Characteristics

PSA：

249.46000

XLogP3：

12.26450

Appearance：

colourless to light-yellow crystal

Density：

1.403 g/mL (20.84 °C)

Melting Point：

237 - 239 °C

Boiling Point：

750.7ºC at 760 mmHg

Flash Point：

68 °F

Refractive Index：

n20/D 1.5520(lit.)

Safety Information

hazard class code：

R43:May cause sensitization by skin contact. R51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment .

safety instructions：

S24-S37-S61

Marks：

Xi,N

Lapatinib ditosylate monohydrate Use and Manufacturing

anticancer binds to a(1), dopamine, histamine H1, muscarinic, and serotonin type 2 (5-HT2) receptors atypical antipsychotic agent

Drug Function and Efficacy

Small molecule 4-anilinoquinazoline receptor tyrosine kinase inhibitor, inhibits epidermal growth factor receptor (ErbB1) and human epidermal growth factor receptor 2 (ErbB2). The half-inhibitory concentrations of breast cancer cell lines BT474 and SKBr3 sensitive to lapatinib are 25 and 32nmol/L, respectively, and enhances the efficacy of cisplatin on bladder cancer cell line RT112. It can inhibit epidermal growth factor-driven tumor growth in animal models and is effective against trastuzumab-resistant tumor cell lines.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Lapatinib Tosylate Tablets
Ingredients	Lapatinib tosylate. Molecular weight: C29H26ClFN4O4S(C7H8O3S)2
Indication	In vitro, lapatinib tablets can inhibit CYP3A4 and CYP2C8 at therapeutic concentrations, and are mainly metabolized by CYP3A4. Drugs that inhibit the activity of this enzyme can significantly increase the blood concentration of lapatinib. Ketoconazole, 0.2g each time, twice a day, can increase the AUC of lapatinib by 3 to 7 times after 7 days, and extend the half-life by 1.7 times. Healthy volunteers took CYP3A4 inducers orally, 100 mg each time, twice a day, and changed to 200 mg each time after 3 days, twice a day for 17 days, and the AUC of lapatinib decreased by 72%. Lapatinib is a transporter of P-glycoprotein, and drugs that inhibit glycoproteins may increase the blood concentration of the drug.
Specifications	0.25g

Lapatinib Tosylate Tablets
Specifications	0.25 g

Lapatinib Tosylate Tablets
Ingredients	Lapatinib tosylate. Molecular weight: C29H26ClFN4O4S(C7H8O3S)2
Indication	In vitro, lapatinib tablets can inhibit CYP3A4 and CYP2C8 at therapeutic concentrations, and are mainly metabolized by CYP3A4. Drugs that inhibit the activity of this enzyme can significantly increase the blood concentration of lapatinib. Ketoconazole, 0.2g each time, twice a day, can increase the AUC of lapatinib by 3 to 7 times after 7 days, and extend the half-life by 1.7 times. Healthy volunteers took CYP3A4 inducers orally, 100 mg each time, twice a day, and changed to 200 mg each time after 3 days, twice a day for 17 days, and the AUC of lapatinib decreased by 72%. Lapatinib is a transporter of P-glycoprotein, and drugs that inhibit glycoproteins may increase the blood concentration of the drug.
Specifications	0.25g

See More Related Drugs

Registered Holders

MSN LABORATORIES PRIVATE LTD

United States
Active
HETERO LABS LTD

United States
Active
CHEMWERTH INC

United States
Active

See More Registered Holders

Recommended Suppliers of Lapatinib ditosylate monohydrate

Hainan Flying International Trade Co., L Contact Supplier

CN
3 YRS

Business licensed

Trader Supplier of vitamin

Hot Selling API Lapatinib Ditosylate powder 388082-78-8 for Best Price

CAS No.: 388082-78-8

Grade: Food grade

Content: 99%

Inquiry
Hangzhou Dawn Ray Pharmaceutical Co.,Ltd Contact Supplier

CN
5 YRS

Business licensed Certified factory

Manufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP

Lapatinib ditosylate

CAS No.: 388082-78-8

Inquiry
Shandong Airuike Chemical Co., Ltd. Contact Supplier

CN
3 YRS

Business licensed

Trader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVE

Lapatinib cas 388082-78-8 in hot sale

CAS No.: 388082-78-8

Grade: Analytical Reagent

Content: 99%

Inquiry
Nanjing CHICO Pharmaceutical Co., Ltd Contact Supplier

CN
8 YRS

Business licensed Certified factory

Manufactory Supplier of Anti-tumor categories,Cardiovascular,Anti-Diabetes Class

Lapatinib Ditosylate 99%

CAS No.: 388082-78-8

Grade: Industrial Grade

Content: 99%

Inquiry
ROYAL PHARM Contact Supplier

CN
4 YRS

Business licensed

Trader Supplier of additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst,API

Lapatinib ditosylate 388082-78-8

CAS No.: 388082-78-8

Grade: Pharmaceutical grade

Content: 99%

Inquiry

Latest News on Lapatinib ditosylate monohydrate

Learn More Other Chemicals

L-Prolinamide, N-acetyl-L-leucyl-, monohydrate

142179-09-7
METHYL ALPHA-D-GALACTOPYRANOSIDE MONOHYDRATE

34004-14-3
Ethanone, 1,1-(1,4-dihydro-2,6-dimethyl-3,5-pyridinediyl)bis-, monohydrate (9CI)

412009-36-0
Strychnidin-10-one, 2,3-dimethoxy-, mono[1-(1,1-dimethylethyl) (2S)-1,2-pyrrolidinedicarboxylate], compd. with ethanol (1:1), monohydrate Formula

908012-07-7
Benzenesulfonamide, N-(aminoiminomethyl)-3,5-bis(trifluoromethyl)-, monohydrate Formula

306935-08-0
Hydrazinecarboximidamide, 2,2′-(1-methyl-1,2-ethanediylidene)bis-, dihydrochloride, monohydrate Formula

24968-67-0
Guanosine, 2'-deoxy-6-thio-, monohydrate Structure

64039-27-6
Ipratropium bromide monohydrate Structure

66985-17-9
What is Diphosphoric acid, copper(2+) salt (1:2), monohydrate

304671-71-4
What is Lanthanum, [μ-[ethanedioato(2-)-κO1,κO2′:κO1′,κO2]]bis[ethanedioato(2-)-κO1,κO2]di-, monohydrate

312696-10-9

Hot Searches: dystrophic toenails; p aminobenzoic acid; formula for hydrogen sulphide; ammonium phosphate formula; toluene sds; potassium sulfide formula

Guide of Lapatinib ditosylate monohydrate

Description
Basic Attributes
Characteristics
Safety Information
Use and Manufacturing
Drug Function and Efficacy
Related Drugs
Registered Holders
Recommended Suppliers
Latest News
Learn More Other Chemicals

Lapatinib ditosylate monohydrate

SDS

Request for Quotation



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.